Concert Pharmaceuticals Inc. sell StockNews.com
Start price
12.03.23
/
50%
€7.88
Target price
12.03.24
-
Performance (%)
0.00%
End price
13.03.24
-
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com is currently unchanged from the start price. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by StockNews_com for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat
In the thread Trading Concert Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

